Veerhealth Care Share Price Today | Stock Price & Veerhealth Care Share Screener
As of October 5, 2026, the live Veerhealth Care share price (BSE: VEERHEALTH) is ₹50.24, up 0.72% from the previous close, with shares trading between ₹49.06 and ₹52.00 in today's trading session, and a 52-week range of ₹16.96–₹50.94. Check VEERHEALTH 52-week high low for the annual price range and momentum. Use the Veerhealth Care stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Veerhealth Care opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹53 and net income of ₹2, with EBITDA of ₹4, an operating margin of 10.0% and a profit margin of 3.8%.
Veerhealth Care Share Price Chart
Track the current stock price of Veerhealth Care with an interactive chart. Analyse VEERHEALTH share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Veerhealth Care stock quote in one place.
The quote of ₹50.24 sits between the 52-week low of ₹16.96 and the 52-week high of ₹50.94, and the latest session moved 0.72% from the previous close.
Veerhealth Care Company Profile - Fundamental Screener
Screen Veerhealth Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VEERHEALTH shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE882C01035.
Company Details
Classification
Identifiers and Leadership
Veerhealth Care Balance Sheet Screener
Screen VEERHEALTH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹44, up from ₹34 in 2025.
Latest statistics put total assets at ₹44 and shareholder funds at ₹23, with a leverage ratio of 0.21.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 44 | 34 | 28 | 25 | 20 | 19 | 18 | 16 | 15 | 13 |
| Current Assets | 19 | 9 | 14 | 10 | 6 | 7 | 6 | 3 | 7 | 8 |
| Fixed Assets | 23 | 20 | 12 | 12 | 11 | 10 | 10 | 6 | 6 | 3 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 8 | 8 | 4 | 3 | 4 | 3 | 3 | 0 | 0 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 23 | 22 | 22 | 21 | 14 | 14 | 14 | 13 | 13 | 13 |
| Share Capital | 20 | 20 | 20 | 10 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | 3 | 2 | 2 | 11 | 7 | 7 | 7 | 6 | 6 | 6 |
Veerhealth Care Income Statement Screener - Profit & Revenue Analysis
Screen Veerhealth Care income statement and profit fundamentals. Analyze VEERHEALTH quarterly results. Veerhealth Care reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹53 and net profit was ₹2, equal to earnings per unit of ₹0.80, at an operating margin of 10%.
In that period expenses were ₹49, interest cost ₹1 and tax ₹1. The next period listed, 2026-March, shows revenue of ₹33 and net profit of ₹1.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||
| Revenue | 53 | 33 | 18 | 15 | 15 | 11 | 12 | 12 | 6 | 6 | 3 | 3 | 2 |
| Expenses | 49 | 30 | 16 | 13 | 13 | 10 | 11 | 11 | 6 | 5 | 2 | 2 | 2 |
Operating Costs and Margins | |||||||||||||
| EBITDA | 4 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Operating Profit % | 10.00% | 8.00% | 5.00% | 5.00% | 4.00% | -9.00% | 1.00% | 6.00% | 7.00% | -2.00% | -19.00% | -1.00% | -12.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||
| Profit Before Tax | 3 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Tax | 1 | 1 | 0 | 1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 2 | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 0.80 | 0.27 | 0.20 | 0.21 | 1.52 | -0.11 | 0.55 | 0.46 | 0.23 | 0.20 | 0.03 | 0.00 | 0.01 |
Veerhealth Care Cash Flow Screener - Liquidity Fundamentals
Screen VEERHEALTH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹4, and net cash flow was an outflow of ₹1.
Over the same period, investing activities used ₹4 and financing activities used ₹1.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 4 | 5 | 3 | -1 | 2 | 1 | 0 | 2 | 2 | 2 |
| Investing Activities | -4 | -8 | 0 | -2 | -1 | 0 | -2 | -2 | -3 | 0 |
Financing and Net Cash | ||||||||||
| Financing Activities | -1 | 5 | -6 | 6 | 0 | -1 | 2 | 0 | 1 | -1 |
| Net Cash Flow | -1 | 1 | -3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
Veerhealth Care Shareholding Pattern Screener
See Veerhealth Care shareholding pattern with promoter, FII, and DII holdings. Check Veerhealth Care promoter holding and ownership changes for VEERHEALTH on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 31.50%, foreign institutions 0.00%, domestic institutions 0.00% and the public 54.27%, spread across 10,027 shareholders.
The shareholder count was 10,027 in 2026-Mar, compared with 9,315 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 31.50% | 31.91% | 31.50% | 31.50% | 31.50% | 31.50% | 30.41% | 30.41% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 54.27% | 53.97% | 58.35% | 57.92% | 56.97% | 55.12% | 60.05% | 59.25% |
| Other Holding | 14.23% | 14.12% | 10.15% | 10.58% | 11.53% | 13.38% | 9.54% | 10.33% |
| Shareholder Count | 10,027 | 9,315 | 11,390 | 11,011 | 10,846 | 10,455 | 10,991 | 10,255 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Veerhealth Care. Veerhealth Care dividend yield can be compared with peers and other stocks in the market.
Veerhealth Care Stock Index Membership - Nifty & Sensex
See which indices include Veerhealth Care stock. Check VEERHEALTH index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Veerhealth Care Market Events Screener - Corporate Actions
Get Veerhealth Care corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Veerhealth Care stock events that may affect VEERHEALTH share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Annual General Meeting dated September 23, 2026, with a record date of September 23, 2026.
It is followed by Quarterly Result Announcement dated August 13, 2026 and Quarterly Result Announcement dated May 30, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-23 | 2026-09-23 | Annual General Meeting | NA | 5.95% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 7.42% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 2.13% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | 7.24% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.31% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | -17.87% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -0.86% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 15.31% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -7.02% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -8.66% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -1.25% |
| 2023-09-22 | 2023-09-22 | Bonus | 1:1 | 1.28% |
Veerhealth Care Competitors Screener - Peer Stocks Comparison
Screen VEERHEALTH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 432,120 | 36.04 | 61,674 | 12.69% | 11,565 | 36.68 |
| Divis Laboratories | 245,532 | 84.24 | 11,067 | 13.95% | 2,568 | 51.70 |
| Torrent Pharmaceuticals | 181,333 | 84.71 | 13,886 | 20.34% | 2,138 | 41.12 |
| Zydus Life Science | 114,284 | 25.27 | 27,658 | 17.64% | 5,026 | 47.64 |
| Cipla | 108,576 | 32.50 | 29,045 | 2.24% | 3,870 | 34.78 |
| Laurus Labs | 107,198 | 98.20 | 6,868 | 22.01% | 890 | 58.70 |
| Mankind Pharma | 104,707 | 50.04 | 14,636 | 14.85% | 1,938 | 61.75 |
| Dr Reddys Laboratories | 100,679 | 32.41 | 35,059 | 3.90% | 4,158 | 53.84 |
| Aurobindo Pharma | 96,479 | 25.84 | 34,145 | 5.56% | 3,503 | 50.30 |
| Lupin | 92,885 | 16.82 | 29,039 | 26.75% | 5,356 | 31.59 |
Veerhealth Care Company Announcements - News & Reports Screener
Screen VEERHEALTH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 4, 2026.
The next most recent announcements are dated September 29, 2026 and September 26, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-04 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | - |
| 2026-09-29 | Closure of Trading Window | - |
| 2026-09-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-23 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-22 | Corrigendum To The Notice Of 34Th Annual General Meeting Of The Shareholders Of Veerhealth Care Ltd To Be Held On 23Rd September 2026 | - |
| 2026-09-11 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-09-09 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | - |
| 2026-09-03 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-09-02 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | - |
| 2026-09-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-31 | Update Regarding Letter Sent To Shareholders | - |
| 2026-08-31 | Shareholder Meeting For 34Th Annual General Meeting For The Financial Year 2025-2026 | - |
| 2026-08-31 | Reg. 34 (1) Annual Report. | - |
| 2026-08-27 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - |
| 2026-08-13 | Appointment of Company Secretary and Compliance Officer | - |
| 2026-08-13 | Results- Financial Results For Quarter Ended June 2026 | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of The Board Meeting | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹50.24, within a 52-week range of ₹16.96 to ₹50.94. The P/E ratio is 64.39 and the P/B ratio is 4.33, with earnings per unit of ₹0.27. Market capitalisation stands at ₹99.74 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.